Fig. 3From: Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitusChoropleth map of all-cause mortality. The map reveals that regional difference of all-cause mortality in Denmark, Israel, Netherlands, UK, and USA. Metformin treatment has no meaningful impact on all-cause mortality versus control, in each countryBack to article page